[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100633173":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":31,"locations":26,"responsibleParty":38,"collaborators":26,"id":42,"slug":43,"hasResults":44,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":44,"sex":50,"minAge":51,"maxAge":52,"enrollmentInfo":53,"targetDuration":26,"studyType":56,"phases":57,"briefSummary":59,"conditions":60,"keywords":64,"overallStatus":70,"whyStopped":26,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":26},{"fullName":5,"class":6},"Istanbul Medipol University Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"ESWT Group","EXPERIMENTAL","Participants in this group will receive extracorporeal shock wave therapy (ESWT) applied to the gastrocnemius and soleus muscles in addition to a standard physiotherapy program including stretching, strengthening, balance, and gait training.",[13],"Device: Extracorporeal Shock Wave Therapy (ESWT)",{"label":15,"type":16,"description":17,"interventionNames":18},"Control Group (Sham ESWT)","SHAM_COMPARATOR","Participants in this group will receive sham ESWT with no therapeutic energy delivery in addition to the same standard physiotherapy program.",[19],"Device: Sham Extracorporeal Shock Wave Therapy",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DEVICE","Extracorporeal Shock Wave Therapy (ESWT)","Radial extracorporeal shock wave therapy will be applied with an energy flux density of 0.10-0.20 mJ\u002Fmm², frequency of 5-8 Hz, and 2000-3000 pulses per muscle. Treatment will be administered three times per week for four weeks.",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Sham Extracorporeal Shock Wave Therapy","A sham ESWT procedure will be performed using the same device without energy transmission, mimicking the sound and sensation of treatment.",[15],[32],{"name":33,"role":34,"phone":35,"phoneExt":36,"email":37},"Mehmet Salih SALİH TAN, Doctoral","CONTACT","Türkiye","+905467266876","mstan@medipol.edu.tr",{"type":39,"investigatorFullName":40,"investigatorTitle":41,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"PRINCIPAL_INVESTIGATOR","salih tan","Assistant Professor","100633173","effect-of-extracorporeal-shock-wave-therapy-on-spasticity-and-mobility-in-stroke-patients-100633173",false,"NCT07523243","Effect of Extracorporeal Shock Wave Therapy on Spasticity and Mobility in Stroke Patients","Efficacy of Extracorporeal Shock Wave Therapy on Spasticity, Mobility, Motor Function, and Health-Related Quality of Life in Stroke Survivors: A Prospective Randomized Sham-Controlled Trial","ESWT-STROKE","Inclusion Criteria:\n\n* Adults aged 18-65 years\n* Diagnosed with ischemic or hemorrhagic stroke at least 3 months prior to enrollment Presence of lower extremity spasticity with a Modified Ashworth Scale (MAS) score ≥1+\n* Ability to walk independently with or without assistive devices\n* Ability to understand and follow instructions for exercise interventions and assessments\n* Provided written informed consent\n\nExclusion Criteria:\n\n* Receipt of botulinum toxin injection in the affected lower limb within the last 3 months\n* Severe cognitive impairment preventing participation in assessments\n* Presence of fixed joint contractures limiting range of motion\n* Orthopedic or musculoskeletal disorders affecting lower limb function (e.g., fracture, severe osteoarthritis)\n* Uncontrolled cardiovascular, respiratory, or systemic disease contraindicating exercise\n* Participation in another interventional clinical trial\n* Any condition judged by the investigator to interfere with participation or safety","ALL","18 Years","65 Years",{"count":54,"type":55},85,"ESTIMATED","INTERVENTIONAL",[58],"NA","This study aims to evaluate the effectiveness of extracorporeal shock wave therapy (ESWT) in individuals with lower limb spasticity following stroke. Spasticity is a common complication after stroke and can negatively affect walking ability, mobility, and quality of life.\n\nParticipants will be randomly assigned to one of two groups. Both groups will receive a standard physiotherapy and rehabilitation program. In addition, the intervention group will receive ESWT applied to the lower limb muscles, while the control group will receive a sham (placebo) ESWT application.\n\nThe treatment program will be conducted three times per week for four weeks. Clinical assessments will be performed at baseline, after treatment, and during follow-up.\n\nThe main outcomes of the study include muscle tone (spasticity), walking performance, motor function, and quality of life. The results of this study may help improve rehabilitation strategies and provide evidence for the use of ESWT in stroke patients.",[61,62,63],"Stroke","Post-Stroke Spasticity","Lower Limb Spasticity",[65,66,67,68,69],"Extracorporeal Shock Wave","ESWT Stroke Rehabilitation","Mobility Fugl-Meyer","Quality of Life","Spasticity","NOT_YET_RECRUITING","2026-04-09",{"date":73,"type":74},"2026-04-14","ACTUAL",{"date":76,"type":55},"2026-04",{"date":78,"type":55},"2026-06-20",{"name":5,"class":6}]